Attention:
Card image cap

Challenges of Hospital-Based Pathology Compensation Arrangements


Level: Advanced
Runtime: 92 minutes
Recorded Date: June 28, 2018
Click here to share this program
Printer-Friendly Version

Agenda


  • Healthcare Law
  • Valuation Basics
  • Pathology Compensation Arrangements
  • Clinical Laboratory Oversight (Part A/Professional Component of Clinical Pathology)
  • Coverage Services (Part B)
  • Technical Component of Anatomical Pathology Services (Part B)
  • Other Pathology Arrangements
  • Observed Statistics for Marketplace Arrangements
  • Preparing for Negotiations
  • Strategies and Techniques
  • Hospital Contracts
Runtime: 1 hour and 32 minutes
Recorded: June 28, 2018
For NY - Difficulty Level: Experienced attorneys only (non-transitional)

Description

This presentation will provide an overview of pathology in the hospital setting from operational, reimbursement, and terminology perspectives.

Pathology and related compensation arrangements differ from other healthcare specialties resulting in challenges even for healthcare-focused attorneys. Furthermore, new pathology arrangement structures are beginning to form in the marketplace, which also must be considered from a legal and value-based standpoint.

Faculty will address certain pathology-specific topics including (i) the need to pay for Part A type services and how such services should be valued when compensated; (ii) payment for the technical component of anatomic pathology; and (iii) risk-based/incentive-based compensation arrangements.

This program was recorded on June 28th, 2018.

Provided By

American Bar Association
Card image cap

Panelists

Card image cap

Jane Pine Wood

Chief Legal Officer
BioReference Laboratories, Inc.

Jane Pine Wood is a licensed and practicing attorney who oversees the company’s Legal Department, with a focus on legal and regulatory compliance, corporate governance and corporate ethics.

Jane joined BioReference after serving nearly three decades in private practice at McDonald Hopkins, LLC. She is a member of the American Health Lawyers Association, and has received the Association of Pathology Chairs’ Friends of Pathology Award, American Society of Clinical Pathology Patients’ Advocate Award, and is listed among Massachusetts Super Lawyers – Top 50 Female Lawyer Award.

She holds her J.D. from Vanderbilt University School of Law and B.A. in History from Texas A&M University.

Card image cap

David W. Sands

Director
HealthCare Appraisers

Mr. Sands is a Director in the Firm’s California office where he specializes in the valuation of complex compensation arrangements which may have Stark and/or Anti-Kickback implications and business valuation. Prior to joining HealthCare Appraisers, Mr. Sands was a private investment manager with Wachovia Securities in Las Olas, Florida.

Mr. Sands currently possesses over eight years of fulltime healthcare consulting and valuation experience. During this time, Mr. Sands has gained exposure to every type of analysis that the Firm provides to clients, and has been instrumental in aiding the development of the Firm’s internal standards, FMV guidance and templates. He is a Certified Valuation Analyst (CVA) and holds a BS in Business Administration with a concentration in Finance from Boston University’s School of Management. He is a Level II Candidate in the Chartered Financial Analyst (CFA) program.


Card image cap

Similar Courses

Card image cap
58 minutes
5 Ways Agreement AI Can Enhance Performance and Reduce Risk for Your Legal Team
In high growth companies, contracting pain points can make your organization less competitive. Fortunately, your legal team has access to world-class, robust AI solutions that can help enhance performance of the legal team and avoid common business pitfalls. If deployed correctly, contract AI can be a legal team’s best friend - shrinking the knowledge gap across years and silos, acting as a digital assistant to automate repetitive tasks, and arming lawyers with tools that help them be proactive rather than responsive.

Legalweek

$65

Add to Cart
Card image cap
118 minutes
A Comprehensive Guide on Non-Fungible Tokens (NFTs): Managing Potentials and Perils
In this program, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the recent trends and significant challenges surrounding NFTs and the associated legal landscape, including helpful insights to avoid potential risks.">In this program, a panel of thought leaders and practitioners assembled by The Knowledge Group will discuss the recent trends and significant challenges surrounding NFTs and the associated legal landscape, including helpful insights to avoid potential risks.

The Knowledge Group

$165

Add to Cart
Card image cap
61 minutes
Accelerating Revenue & Sales Cycles with the Use of Contract Automation
When implemented correctly, automating repetitive tasks in the contract lifecycle process should accelerate the sales cycle without compromising Legal's function as a primary risk manager. When you implement effective, automated document and contract management solutions, you will reduce risk, improve visibility and accelerate cycles.

Legalweek

$65

Add to Cart
Card image cap
74 minutes
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
Previous Next